Commercial

Infographic | The leaders of the global hepatitis-C market

Despite approvals of competing products from AbbVie, Merck, and Bristol-Myers Squibb, Gilead remains the market leader.

Virginia Lau

August 31, 2017

11:00 am

From the September 01, 2017 Issue of MM+M - Medical Marketing and Media

From Our Partners

Partner Content

Mapping the identity experience in digital health communications

How IX offers greater nuance in engaging with audiences.

Partner Content

The state of DE&I: Moving the needle from commitment to progress

Employees and consumers alike expect companies to take meaningful steps toward creating a more equitable and inclusive future. As shown by the findings from MM+M’s 2022 Diversity Survey, conducted in partnership with IPG Health, progress has been made but we still have a long way to go in the healthcare industry.

Partner Content

How to keep digital pharma marketing relevant in the times of global crises

Nataliya Andreychuk, CEO of Viseven, discusses digital marketing trends and more during her chat with Marc Iskowitz, editor-at-large, MM+M.

Partner Content

Why marketers must make the switch to privacy-safe real-world data for targeting

Developing more precise and brand-exclusive patient segments with higher audience quality.

HAYMARKET MARKETING COMMUNICATIONS:

HAYMARKET MARKETING COMMUNICATIONS:

Quick Links

Infographic | The leaders of the global hepatitis-C market

MM+M Media Summit 2022

From Our Partners

Partner Content

Mapping the identity experience in digital health communications

Partner Content

The state of DE&I: Moving the needle from commitment to progress

Partner Content

How to keep digital pharma marketing relevant in the times of global crises

Partner Content

Why marketers must make the switch to privacy-safe real-world data for targeting

Thank you for accessing MM+M.